Skip to main content
OpenTrials

Clinical trial condition

Malignant Melanoma

Explore clinical trials studying Malignant Melanoma. Study availability and eligibility vary by location and protocol.

168 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Malignant Melanoma trial results

Completed

A Study of Vemurafenib in Participants With Metastatic Melanoma

NCT01307397

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • University "Mother Theresa" Hospital Center; Oncology Department Tirana, Albania
  • Hospital Britanico; Oncologia Buenos Aires, Argentina
  • Fundación CIDEA Buenos Aires, Argentina
  • Inst. Alexander Fleming; Oncologia Buenos Aires, Argentina
View all 280 locations
View Trial Details
Completed

Safety Study of PLX4032 in Patients With Solid Tumors

NCT00405587

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +20 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

NCT01001299

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • UCLA - School of Medicine Los Angeles, California, United States
  • Massachusetts General Hospital;Hematology/ Oncology Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Ctr Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma

NCT00949702

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • UCLA - School of Medicine; Division of Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital;Hematology/ Oncology Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Completed

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

NCT02143999

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica Chieti, Abruzzo, Italy
  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari Bari, Apulia, Italy
  • IRCCS IST. Tumori Fondaz. Pascale; S.C. Oncologia Medica,Melanoma,Immunoterapia E Terapie Innovative Naples, Campania, Italy
  • Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica Bologna, Emilia-Romagna, Italy
View all 24 locations
View Trial Details

Related conditions